Patients' perspectives related to ethical issues and risks in precision medicine: a systematic review

Abstract

BackgroundPrecision medicine is growing due to technological advancements including next generation sequencing techniques and artificial intelligence. However, with the application of precision medicine many ethical and potential risks may emerge. Although, its benefits and potential harms are relevantly known to professional societies and practitioners, patients' attitudes toward these potential ethical risks are not well-known. The aim of this systematic review was to focus on patients' perspective on ethics and risks that may rise with the application of precision medicine.MethodsA systematic search was conducted on 4/1/2023 in the database of PubMed, for the period 1/1/2012 to 4/1/2023 identifying 914 articles. After initial screening, only 50 articles were found to be relevant. From these 50 articles, 24 articles were included in this systematic review, 2 articles were excluded as not in English language, 1 was a review, and 23 articles did not include enough relevant qualitative data regarding our research question to be included. All full texts were evaluated following PRISMA guidelines for reporting systematic reviews following the Joanna Briggs Institute criteria.ResultsThere were eight main themes emerging from the point of view of the patients regarding ethical concerns and risks of precision medicine: privacy and security of patient data, economic impact on the patients, possible harms of precision medicine including psychosocial harms, risk for discrimination of certain groups, risks in the process of acquiring informed consent, mistrust in the provider and in medical research, issues with the diagnostic accuracy of precision medicine and changes in the doctor-patient relationship.ConclusionEthical issues and potential risks are important for patients in relation to the applications of precision medicine and need to be addressed with patient education, dedicated research and official policies. Further research is needed for validation of the results and awareness of these findings can guide clinicians to understand and address patients concerns in clinical praxis.

How to translate genetic findings into clinical applications in spondyloarthritis?

“…A first concern is the risk of discrimination in employment or health insurance addressed by the emerging concept of “genetic discrimination” ( 42 ). Another point to consider is the cost which might lead to an unequal access to precision medicine ( 43 ).…”

Ethical frameworks of informed consent in the age of pediatric precision medicine

“…Notably, a review of patient perspectives related to ethical issues in precision medicine by Ahmed et al ( 2023 ) identified several emergent themes, including data governance, patient costs, risks for discrimination, issues with the diagnostic accuracy and psychosocial implications of the findings. Future research is needed to evaluate how these ethical issues can be addressed in part through revised informed consent processes, with a particular emphasis on the need to consider pediatric patients as a growing patient population involved in precision medicine.…”

The Untouched Reserve of Cancer Chemotherapy: Tumor Cell Communication as a Promising Supramolecular Target

“…With such a high upfront price, only some patients can manage to pay for the medications. Also, such prices leave low-and middle-income countries out of personalized treatment (for a recent review, see [165]). We think that the approach proposed in this review would serve as basis for a desirable, inexpensive, and universal clinical procedure.…”